Prothena Plc Net Income From Continuing Ops Over Time

PRTA Stock  USD 14.53  0.75  5.44%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Prothena Plc Performance and Prothena Plc Correlation.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.
  
The current year's Net Loss is expected to grow to about (139.7 M).
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.46)
Revenue Per Share
2.482
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.16)
Return On Equity
(0.23)
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Net Income From Continuing Ops Analysis

Compare Prothena plc and related stocks such as Scpharmaceuticals, Milestone Pharmaceuticals, and Oncolytics Biotech Net Income From Continuing Ops Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
SCPH(10.5 M)(10.5 M)(10.5 M)(10.5 M)(10.5 M)(10.5 M)(24.4 M)(23.8 M)(29.4 M)(33 M)(32.2 M)(28 M)(36.8 M)(50.2 M)(47.7 M)
MIST(8.1 M)(8.1 M)(8.1 M)(8.1 M)(8.1 M)(8.1 M)(8.1 M)(8.1 M)(23.2 M)(55.2 M)(50 M)(42.9 M)(58.4 M)(59.3 M)(62.2 M)
ONCY0.00.00.00.0(16 M)(5.2 M)(15.1 M)(15.6 M)(17 M)(33.1 M)(22.5 M)(26.3 M)(24.8 M)(32.4 M)(30.7 M)
MCRB(16.7 M)(16.7 M)(16.7 M)(16.7 M)(16.7 M)(54.8 M)(91.6 M)(89.4 M)(98.9 M)(70.3 M)(89.1 M)(65.6 M)(250.2 M)(141.3 M)(148.3 M)
ETNB(16.2 M)(16.2 M)(16.2 M)(16.2 M)(16.2 M)(16.2 M)(16.2 M)(16.2 M)(16.2 M)(57.4 M)(49.5 M)(90.1 M)(102 M)(126.6 M)(120.2 M)
MDGL(47.4 M)(47.4 M)(62.8 M)(90.2 M)(86.2 M)(68.7 M)(26.4 M)(31.5 M)(33 M)(83.9 M)(202.3 M)(242.1 M)(295.4 M)(373.6 M)(354.9 M)
PLRX(30.3 M)(30.3 M)(30.3 M)(30.3 M)(30.3 M)(30.3 M)(30.3 M)(30.3 M)(30.3 M)(631 K)(41.5 M)(97.3 M)(123.3 M)(155.3 M)(147.5 M)
ACLX(18 M)(18 M)(18 M)(18 M)(18 M)(18 M)(18 M)(18 M)(18 M)(18 M)(32.1 M)(65 M)(188.7 M)(129.5 M)(136 M)
STOK(5.6 M)(5.6 M)(5.6 M)(5.6 M)(5.6 M)(5.6 M)(5.6 M)(5.6 M)(12.5 M)(32.3 M)(52.2 M)(85.8 M)(101.1 M)(103.4 M)(98.2 M)
VTYX(4.3 M)(4.3 M)(4.3 M)(4.3 M)(4.3 M)(4.3 M)(4.3 M)(4.3 M)(4.3 M)(4.3 M)(28.2 M)(83.7 M)(108.4 M)(181.4 M)(172.4 M)
IMCR(71.6 M)(71.6 M)(71.6 M)(71.6 M)(71.6 M)(71.6 M)(71.6 M)(71.6 M)(71.6 M)(103.9 M)(74.1 M)(131.5 M)(41.2 M)(54.1 M)(56.8 M)
PCVX(29.5 M)(29.5 M)(29.5 M)(29.5 M)(29.5 M)(29.5 M)(29.5 M)(29.5 M)(29.5 M)(50.3 M)(89.2 M)(100.1 M)(223.5 M)(402.3 M)(382.2 M)
NUVL(11.8 M)(11.8 M)(11.8 M)(11.8 M)(11.8 M)(11.8 M)(11.8 M)(11.8 M)(11.8 M)(11.8 M)(14.6 M)(46.3 M)(81.9 M)(114 M)(108.3 M)
CGEM(704.7 K)(704.7 K)(704.7 K)(704.7 K)(130.5 K)(109.5 K)(316.7 K)(14.2 M)(14.2 M)(21.7 M)(59.5 M)(65.6 M)109.2 M(155.1 M)(147.3 M)
KNSA(24 M)(24 M)(24 M)(24 M)(24 M)(24 M)(24 M)(64.9 M)(103.2 M)(161.9 M)(161.4 M)(157.9 M)183.4 M(6.7 M)(7 M)
VRDN(26.5 M)(26.5 M)(26.5 M)(26.5 M)(26.5 M)(26.5 M)(26.5 M)(26.5 M)(32.7 M)(41.9 M)(110.7 M)(79.6 M)(130.1 M)(216.7 M)(205.8 M)

Prothena plc and related stocks such as Scpharmaceuticals, Milestone Pharmaceuticals, and Oncolytics Biotech Net Income From Continuing Ops description

My Equities

My Current Equities and Potential Positions

Prothena plc
PRTA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationIreland
ExchangeNASDAQ Exchange
USD 14.53
When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:
Check out Prothena Plc Performance and Prothena Plc Correlation.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Prothena Plc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Prothena Plc technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Prothena Plc trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...